SARS-CoV-2 infection: efficacy of extensive vaccination of the healthcare workforce in a large Italian hospital

被引:0
作者
Coggiola, Maurizio [1 ]
Clemente, Giuseppe [1 ]
Frammartino, Roberto [1 ]
Grillo, Eugenio [1 ]
Corradi, Alessio [2 ]
Corezzi, Michele [2 ]
Kakaa, Omar [2 ]
Paradisi, Ettore [1 ]
Tuffanelli, Alessandro [1 ]
Pensamiento, Maria Carolina Alfonso [1 ]
Godono, Alessandro [1 ]
Pira, Enrico [1 ]
机构
[1] Univ Hosp Citta Salute & Sci Turin, Dept Occupat Med, Turin, Italy
[2] Univ Turin, Dept Sci Publ Hlth & Pediat, Turin, Italy
来源
MEDICINA DEL LAVORO | 2021年 / 112卷 / 06期
关键词
  mRNA vaccine; intra-hospital epidemic; prevention; biological risk; COVID-19; COVID-19; WORKERS; BNT162B2;
D O I
10.23749/mdl.v112i6.12125
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: A prospective observational study involved 13,787 Health Care Workers (HCWs) of a large hospital to assess the effectiveness of a SARS-CoV-2 mRNA vaccine. Methods: The daily incidence of infections was estimated from 1st October 2020 to 30th April 2021 and compared with that of the province of Turin (2.26 million). In the middle of this period, a mass vaccination began among HCW, and its effect was assessed. Results: In the first half-period, 1,163 positive HCWs were observed, the average daily incidence rate per 100,000 being 79.58 (+/- 15.58; 95% CI) compared to 38.54 (+/- 5.96; 95% CI) in the general population (p<0.001). The vaccination campaign immunized 9,843 HCWs; among them, the average daily incidence was 14.23 (+/- 2.73; 95% CI) compared to 34.2 (+/- 2.95; 95% CI) in the province (p<0.001). Among fully vaccinated HCW, 59 cases were observed, giving rise to an incidence of 6.3 (+/- 2.66; 95% CI) much lower than in the province (p<0.001). In the second half of the observation period, the RR for HCWs compared to the province dropped from 2.07 (1.96 2.18; 95% CI; p<0.001) to 0.5 (0.42 0.58; 95% CI; p<0.001) and to 0.17 (0.13 0.22; 95% CI; p<0.001) for unvaccinated and vaccinated HCWs, respectively. The RR of vaccinate HCW was 0.43 (0.31 0.58; 95% CI; p<0.001) compared to unvaccinated. In the second half of the observation period, unvaccinated HCWs had a RR of 0.21 (0.18 0.25; 95% CI; p<0.001) as compared to the first one. A linear regression model (R2 = 0.87) showed that every percent increase in vaccinated HCWs lowered daily incidence by 0.94 (0.86 1.02; IC 95%; p<0.001). Vaccinated HCWs had a RR of 0.09 (0.07 0.12; 95% CI; p<0.001) compared to unvaccinated HCWs, which led to estimated effectiveness of the two-dose vaccine of 91 % (+/- 3 %; CI 95%) similar to that reported by the manufacturer.
引用
收藏
页码:465 / 476
页数:12
相关论文
共 33 条
[1]   Postvaccination COVID-19 among Healthcare Workers, Israel [J].
Amit, Sharon ;
Beni, Sharon Alexsandra ;
Biber, Asaf ;
Grinberg, Amir ;
Leshem, Eyal ;
Regev-Yochay, Gili .
EMERGING INFECTIOUS DISEASES, 2021, 27 (04) :1220-1222
[2]   Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers [J].
Angel, Yoel ;
Spitzer, Avishay ;
Henig, Oryan ;
Saiag, Esther ;
Sprecher, Eli ;
Padova, Hagit ;
Ben-Ami, Ronen .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (24) :2457-2465
[3]  
[Anonymous], COM AIFA N 620 AUT V
[4]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[5]  
Coggiola M, 2021, MED LAV, V112, pxxx
[6]   BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting [J].
Dagan, Noa ;
Barda, Noam ;
Kepten, Eldad ;
Miron, Oren ;
Perchik, Shay ;
Katz, Mark A. ;
Hernan, Miguel A. ;
Lipsitch, Marc ;
Reis, Ben ;
Balicer, Ran D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15) :1412-1423
[7]  
ECDC, 2021, RISK SARS COV 2 TRAN
[8]  
EMA, COM EPAR
[9]  
EMA. European Medicines Agency (EMA), 2021, EMA NEWS 0210
[10]  
EMA. European Medicines Agency (EMA), COVID 19 VACC OV 202